Sandostatin for Control of GH, IGF-1, Gastrointestinal HormoneSandostatin LAR Information
Sandostatin LAR Octreotide IM Injection












Search
 
  Administering Sandostatin® LAR®  

With its slow-release pharmacokinetic profile compared to Sandostatin® Injection, Sandostatin® LAR® can be administered once a month instead of 3 times a day, which may lead to enhanced patient compliance. In addition, improvements such as a new pre-filled vehicle syringe and redesigned needle size make mixing and administering Sandostatin® LAR® easier than ever.

Click on the following links for more detailed information on administering Sandostatin® LAR®.

To review frequently asked questions and answers on administering Sandostatin® LAR®, click here.

 
  Injection  

Unique formulation eases injections
With its slow release pharmacokinetic profile, Sandostatin® LAR® can be administered once a month, reducing the need for frequent injections. An advanced microsphere formulation provides dependable, state-of-the-art delivery of octreotide, and a single injection provides smooth, consistent drug levels for the entire once-monthly treatment period, at all doses.16

16 Lancranjan I, et al. Sandostatin® LAR®: pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients. Metabolism. 1995;44(suppl 1):18-26

Enhanced needle size eases injections
A new, redesigned 1.1-mm-diameter 19-gauge needle size helps prevent clogging and facilitates easier administration of Sandostatin® LAR®.

 
  Administration  

Sandostatin® LAR® must be administered immediately after suspension.

To properly administer the injection, follow the steps below:

  • Eliminate air from syringe. Continually rock syringe gently to maintain uniform suspension
  • Disinfect injection site with alcohol swab
  • Insert needle deep into right or left gluteus, and if no blood vessel has been penetrated, slowly inject suspension intra-muscularly (IM) with steady pressure
*Keep rocking the syringe gently before injection to maintain a uniform suspension

*Sandostatin® LAR® must be given only by deep IM injection,
never IV

*If blood vessel is penetrated or if needle clogs, replace with new 1.1-mm diameter, 19-gauge needle

Click here to see more injection points.

You may download a printable copy of the preparation steps and proper administration technique. To view and print it, you'll need to install a copy of the free Adobe® Acrobat® ReaderTM, if you don't already have it.

Information about using PDF files

 
 
Learn More
Novartis Core Labeling Text
FAQ